Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Tirat Carmel Mental Health Center
Sponsor:
Collaborators:
Technion, Israel Institute of Technology
Ben-Gurion University of the Negev
Beersheva Mental Health Center
Sha’ar Menashe Mental Health Center
HaEmek Medical Center, Israel
The Nazareth Hospital, Israel
Information provided by (Responsible Party):
Anatoly Dr. Kreinin, Tirat Carmel Mental Health Center
ClinicalTrials.gov Identifier:
NCT01663077
First received: July 25, 2012
Last updated: November 14, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)